Boston Scientific Elects David Habiger to Board of Directors
Boston Scientific (NYSE: BSX) has announced the election of David Habiger to its board of directors, effective immediately. Habiger brings over 30 years of business leadership experience and currently serves as president and CEO of J.D. Power. He has previously led several technology companies and is a director on the Chicago Federal Reserve Board. Boston Scientific's CEO, Mike Mahoney, welcomed Habiger, citing his experience in leading technology companies through pivotal growth periods as a valuable asset to the company's board.
Habiger's extensive background includes founding Silicon Media Partners and serving as CEO for companies like Textura, NDS Group, and Sonic Solutions. He holds an M.B.A. from The University of Chicago and a bachelor's degree in business administration from St. Norbert College. His appointment is expected to contribute to Boston Scientific's ongoing efforts to deliver transformative healthcare solutions.
Boston Scientific (NYSE: BSX) ha annunciato l'elezione di David Habiger nel suo consiglio di amministrazione, con effetto immediato. Habiger porta con sé oltre 30 anni di esperienza nella leadership aziendale e attualmente ricopre il ruolo di presidente e CEO di J.D. Power. In passato ha guidato diverse aziende tecnologiche ed è direttore del Consiglio della Federal Reserve di Chicago. Il CEO di Boston Scientific, Mike Mahoney, ha accolto Habiger, evidenziando la sua esperienza nel guidare aziende tecnologiche durante periodi di crescita decisivi come un prezioso contributo per il consiglio dell'azienda.
Il vasto background di Habiger include la fondazione di Silicon Media Partners e il ruolo di CEO in aziende come Textura, NDS Group e Sonic Solutions. Possiede un M.B.A. presso l'Università di Chicago e una laurea in amministrazione aziendale presso il St. Norbert College. Si prevede che la sua nomina contribuirà agli sforzi in corso di Boston Scientific per fornire soluzioni sanitarie trasformative.
Boston Scientific (NYSE: BSX) ha anunciado la elección de David Habiger para su junta directiva, con efecto inmediato. Habiger aporta más de 30 años de experiencia en liderazgo empresarial y actualmente es presidente y CEO de J.D. Power. Anteriormente, ha liderado varias empresas de tecnología y es director en la Junta de la Reserva Federal de Chicago. El CEO de Boston Scientific, Mike Mahoney, dio la bienvenida a Habiger, citando su experiencia en liderar empresas tecnológicas durante periodos de crecimiento cruciales como un activo valioso para la junta de la compañía.
El extenso historial de Habiger incluye la fundación de Silicon Media Partners y su labor como CEO en empresas como Textura, NDS Group y Sonic Solutions. Tiene un M.B.A. de la Universidad de Chicago y una licenciatura en administración de empresas del St. Norbert College. Se espera que su nombramiento contribuya a los esfuerzos continuos de Boston Scientific para ofrecer soluciones de atención médica transformadoras.
보스턴 사이언티픽 (NYSE: BSX)은 David Habiger를 이사회에 즉시 선임했다. Habiger는 30년 이상의 비즈니스 리더십 경험을 갖고 있으며 현재 J.D. Power의 사장 겸 CEO로 활동 중이다. 그는 이전에 여러 기술 회사를 이끌었으며 시카고 연방준비은행 이사로 활동하고 있다. 보스턴 사이언티픽의 CEO인 Mike Mahoney는 Habiger를 환영하며, 기술 회사들을 결정적인 성장기를 통해 이끌어온 그의 경험이 회사 이사회에 귀중한 자산이 될 것이라고 밝혔다.
Habiger의 풍부한 경력에는 Silicon Media Partners의 설립과 Textura, NDS Group, Sonic Solutions와 같은 회사의 CEO로 활동한 경험이 포함된다. 그는 시카고 대학교에서 MBA를 취득했으며 St. Norbert College에서 경영학 학사 학위를 받았다. 그의 임명은 보스턴 사이언티픽이 혁신적인 의료 솔루션을 제공하기 위한 지속적인 노력에 기여할 것으로 예상된다.
Boston Scientific (NYSE: BSX) a annoncé l'élection de David Habiger à son conseil d'administration, avec effet immédiat. Habiger dispose de plus de 30 ans d'expérience en leadership commercial et occupe actuellement le poste de président et CEO de J.D. Power. Il a précédemment dirigé plusieurs entreprises technologiques et est directeur au Conseil de la Réserve fédérale de Chicago. Le CEO de Boston Scientific, Mike Mahoney, a accueilli Habiger, citant son expérience à diriger des entreprises technologiques durant des périodes de croissance décisives comme un atout précieux pour le conseil de l'entreprise.
Le vaste parcours de Habiger comprend la fondation de Silicon Media Partners et son rôle de CEO dans des entreprises telles que Textura, NDS Group et Sonic Solutions. Il détient un MBA de l'Université de Chicago et une licence en administration des affaires du St. Norbert College. Son nommer est attendu pour contribuer aux efforts continus de Boston Scientific afin de fournir des solutions de santé transformatrices.
Boston Scientific (NYSE: BSX) hat die Wahl von David Habiger in seinen Vorstand bekannt gegeben, die mit sofortiger Wirkung in Kraft tritt. Habiger bringt über 30 Jahre Erfahrung in der Unternehmensführung mit und ist derzeit Präsident und CEO von J.D. Power. Zuvor leitete er mehrere Technologieunternehmen und ist Direktor im Vorstand der Chicagoer Federal Reserve. Der CEO von Boston Scientific, Mike Mahoney, begrüßte Habiger und betonte dessen Erfahrung in der Leitung von Technologieunternehmen während entscheidender Wachstumsphasen als wertvolle Bereicherung für den Unternehmensvorstand.
Habigers umfangreicher Hintergrund umfasst die Gründung von Silicon Media Partners sowie die Rolle als CEO in Unternehmen wie Textura, NDS Group und Sonic Solutions. Er hat einen MBA von der University of Chicago und einen Bachelor-Abschluss in Betriebswirtschaft von St. Norbert College. Seiner Ernennung wird erwartet, dass sie den fortwährenden Bemühungen von Boston Scientific zur Bereitstellung transformierender Gesundheitslösungen zugutekommt.
- Addition of an experienced business leader to the board of directors
- Potential for fresh insights from Habiger's technology sector experience
- Strengthening of the board's expertise in navigating growth periods
- None.
Habiger has more than 30 years of business leadership experience and currently serves as president and chief executive officer of J.D. Power. Prior to joining J.D. Power in 2018, he founded and was a partner of Silicon Media Partners. Earlier in his career, he served as the chief executive officer for multiple private and publicly held technology companies including Textura, NDS Group and Sonic Solutions.
Habiger is a director on the Chicago Federal Reserve Board where he serves on the Governance, Human Resources and SABOR (Systems Activities, Bank Operations and Risk) Committees. He is also a director of several public and private boards and a member of the board of trustees at Rush University Medical Center. Habiger received an M.B.A. from The University of
"We are pleased to expand our board of directors with an accomplished executive who brings a wealth of experience leading technology companies through times of pivotal growth," said Mike Mahoney, chief executive and chairman of the board, Boston Scientific. "We welcome Dave and look forward to his insights as Boston Scientific continues to deliver solutions that transform lives."
About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X, formerly Twitter.
CONTACTS | |
Media: | Investors: |
Chanel Hastings | Jon Monson |
508-382-0288 (office) | 508-683-5450 (office) |
Media Relations | Investor Relations |
Boston Scientific Corporation | Boston Scientific Corporation |
View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-elects-david-habiger-to-board-of-directors-302210247.html
SOURCE Boston Scientific Corporation
FAQ
Who is the new board member elected to Boston Scientific (BSX)?
What is David Habiger's background before joining Boston Scientific's (BSX) board?
How might David Habiger's experience benefit Boston Scientific (BSX)?
When does David Habiger's appointment to Boston Scientific's (BSX) board take effect?
